Despite PAX3::FOXO1 being dispensable in the short turn to tumor cell growth, PAX3::FOXO1 is nonetheless critical to mediate a G2-specific, Survivin/IAP-mediated process of chemotherapy resistance called cell cycle checkpoint adaptation3–5,22. The gene discussed is BIRC5; the disease is neoplasm.